MedTrace Logo

Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy

NCT02711449 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2016-09-27

No results posted yet for this study

Summary

To test whether 125 mg preoperative methylprednisolone intravenously can reduce postoperative pain after laparoscopy for suspected appendicitis and to test whether preoperative methylprednisolone can reduce postoperative fatigue, increase quality of sleep, reduce nausea or vomiting, reduce duration of convalescence and increase overall quality of recovery after laparoscopy for suspected appendicitis.

Conditions

  • Suspected Appendicitis

Interventions

DRUG

Methylprednisolone

125 mg methylprednisolone as an intravenously bolus injection approximately 30 minutes prior to skin incision.

DRUG

0.9% Saline

0,9% Saline as an intravenously bolus injection approximately 30 minutes prior to skin incision.

Sponsors & Collaborators

  • Zealand University Hospital

    collaborator OTHER

  • Jakob Kleif

    lead OTHER

Principal Investigators

  • Jakob Kleif, M.D. · Nordsjaellands Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02711449 on ClinicalTrials.gov